Faculty who have authored publication A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours.
Name | Title | Department | Institution |
---|---|---|---|
Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |